ANAVEX LIFE SCIENCES CORP. Debt Instrument, Convertible, Number of Equity Instruments
ANAVEX LIFE SCIENCES CORP. (AVXL) reported Debt Instrument, Convertible, Number of Equity Instruments of 1.16 thousand N for the 9-month period ending 2016-06-30, per its 10-Q filed 2016-08-11.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentConvertibleNumberOfEquityInstruments · last filed 2017-12-11
- ANAVEX LIFE SCIENCES CORP. debt instrument, convertible, number of equity instruments for the quarter ending 2015-12-31 was 1.16K N, a 99.92% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. debt instrument, convertible, number of equity instruments for the quarter ending 2014-12-31 was 1.40M N.
- ANAVEX LIFE SCIENCES CORP. debt instrument, convertible, number of equity instruments for fiscal 2015 was 7.27M N, a 356.07% increase from fiscal 2014.
- ANAVEX LIFE SCIENCES CORP. debt instrument, convertible, number of equity instruments for fiscal 2014 was 1.59M N.
N
| Period end | Debt Instrument, Convertible, Number of Equity Instruments 3 month | Debt Instrument, Convertible, Number of Equity Instruments 6 month | Debt Instrument, Convertible, Number of Equity Instruments 9 month | Debt Instrument, Convertible, Number of Equity Instruments 12 month |
|---|---|---|---|---|
| 2016-06-30 | 1.16K N 10-Q · filed 2016-08-11 | |||
| 2016-03-31 | 1.16K N 10-Q · filed 2016-05-11 | |||
| 2015-12-31 | 1.16K N 10-Q · filed 2016-02-08 | |||
| 2015-09-30 | 7.27M N 10-K · filed 2015-12-29 | |||
| 2015-06-30 | 5.81M N 10-Q · filed 2016-08-11 | |||
| 2015-03-31 | 3.92M N 10-Q · filed 2016-05-11 | |||
| 2014-12-31 | 1.40M N 10-Q · filed 2016-02-08 | |||
| 2014-09-30 | 1.59M N 10-K · filed 2015-12-29 |
Number
| Period end | Debt Instrument, Convertible, Number of Equity Instruments 12 month |
|---|---|
| 2015-09-30 | 7.27M Number 10-K · filed 2017-12-11 |
| 2014-09-30 | 1.59M Number 10-K · filed 2016-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |